Tag: abbreviated new drug application
April 4, 2019
Teligent Receives FDA Approval of Fluocinonide Cream USP, 0.1 Percent
Teligent (NASDAQ:TLGT) has announced it has received approval for its abbreviated new drug application from the US Food and Drug... November 27, 2018
Akorn Receives Product Approval
Akorn (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, announced that it received a new Abbreviated New Drug Application (ANDA) approval... October 29, 2018
